Cardiotoxicity Associated with Gemcitabine: Literature Review and a Pharmacovigilance Study

Cardiotoxicity Associated with Gemcitabine: Literature Review and a Pharmacovigilance Study

Background: Gemcitabine is a nucleoside analog, widely used either alone or in combination, for the treatment of multiple cancers. However, gemcitabine may also be associated with cardiovascular adverse-drug-reactions (CV-ADR). Methods: First, we searched for all cases of cardiotoxicity associated w...

Full description

Bibliographic Details
Main Authors: Marc Hilmi, Stéphane Ederhy, Xavier Waintraub, Christian Funck-Brentano, Ariel Cohen, Aurore Vozy, Bénédicte Lebrun-Vignes, Javid Moslehi, Lee S. Nguyen, Joe-Elie Salem
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Pharmaceuticals
Subjects:
gemcitabine
pericarditis
myocardial ischemia
heart failure
arrhythmias
cardio-oncology
Online Access:https://www.mdpi.com/1424-8247/13/10/325

Internet

https://www.mdpi.com/1424-8247/13/10/325

Similar Items